130 related articles for article (PubMed ID: 7577943)
41. Mutations and homologous recombination induced in mammalian cells by metabolites of benzo[a]pyrene and 1-nitropyrene.
Maher VM; Patton JD; Yang JL; Wang YY; Yang LL; Aust AE; Bhattacharyya N; McCormick JJ
Environ Health Perspect; 1987 Dec; 76():33-9. PubMed ID: 3129287
[TBL] [Abstract][Full Text] [Related]
42. Mutagenicity of benzo[a]pyrene-deoxyadenosine adducts in a sequence context derived from the p53 gene.
Khalili H; Zhang FJ; Harvey RG; Dipple A
Mutat Res; 2000 Feb; 465(1-2):39-44. PubMed ID: 10708967
[TBL] [Abstract][Full Text] [Related]
43. Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers.
Denissenko MF; Pao A; Pfeifer GP; Tang M
Oncogene; 1998 Mar; 16(10):1241-7. PubMed ID: 9546425
[TBL] [Abstract][Full Text] [Related]
44. Repair analysis of promutagenic (+)-anti-BPDE DNA adduct in transcriptionally active sequences of plasmid DNA in Escherichia coli.
Musarrat J; Arezina-Wilson J; Venkatachalam S; Wani AA
Biochim Biophys Acta; 1997 Mar; 1351(1-2):203-12. PubMed ID: 9116034
[TBL] [Abstract][Full Text] [Related]
45. Free-energy perturbation methods to study structure and energetics of DNA adducts: results for the major N2-dG adduct of benzo[a]pyrene in two conformations and different sequence contexts.
Chandani S; Lee CH; Loechler EL
Chem Res Toxicol; 2005 Jul; 18(7):1108-23. PubMed ID: 16022503
[TBL] [Abstract][Full Text] [Related]
46. Mutagenic specificity of a potent carcinogen, benzo[c]phenanthrene (4R,3S)-dihydrodiol (2S,1R)-epoxide, which reacts with adenine and guanine in DNA.
Bigger CA; Strandberg J; Yagi H; Jerina DM; Dipple A
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2291-5. PubMed ID: 2648399
[TBL] [Abstract][Full Text] [Related]
47. Solution conformation of the major adduct between the carcinogen (+)-anti-benzo[a]pyrene diol epoxide and DNA.
Cosman M; de los Santos C; Fiala R; Hingerty BE; Singh SB; Ibanez V; Margulis LA; Live D; Geacintov NE; Broyde S
Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1914-8. PubMed ID: 1311854
[TBL] [Abstract][Full Text] [Related]
48. Base sequence dependence of in vitro translesional DNA replication past a bulky lesion catalyzed by the exo- Klenow fragment of Pol I.
Zhuang P; Kolbanovskiy A; Amin S; Geacintov NE
Biochemistry; 2001 Jun; 40(22):6660-9. PubMed ID: 11380261
[TBL] [Abstract][Full Text] [Related]
49. Sequence context- and temperature-dependent nucleotide excision repair of a benzo[a]pyrene diol epoxide-guanine DNA adduct catalyzed by thermophilic UvrABC proteins.
Ruan Q; Liu T; Kolbanovskiy A; Liu Y; Ren J; Skorvaga M; Zou Y; Lader J; Malkani B; Amin S; Van Houten B; Geacintov NE
Biochemistry; 2007 Jun; 46(23):7006-15. PubMed ID: 17506530
[TBL] [Abstract][Full Text] [Related]
50. Suppressive activities of OGG1 and MYH proteins against G:C to T:A mutations caused by 8-hydroxyguanine but not by benzo[a]pyrene diol epoxide in human cells in vivo.
Yamane A; Shinmura K; Sunaga N; Saitoh T; Yamaguchi S; Shinmura Y; Yoshimura K; Murakami H; Nojima Y; Kohno T; Yokota J
Carcinogenesis; 2003 Jun; 24(6):1031-7. PubMed ID: 12807753
[TBL] [Abstract][Full Text] [Related]
51. Interactions between DNA polymerase beta and the major covalent adduct of the carcinogen (+)-anti-benzo[a]pyrene diol epoxide with DNA at a primer-template junction.
Singh SB; Beard WA; Hingerty BE; Wilson SH; Broyde S
Biochemistry; 1998 Jan; 37(3):878-84. PubMed ID: 9454577
[TBL] [Abstract][Full Text] [Related]
52. Mutational properties of the primary aflatoxin B1-DNA adduct.
Bailey EA; Iyer RS; Stone MP; Harris TM; Essigmann JM
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1535-9. PubMed ID: 8643667
[TBL] [Abstract][Full Text] [Related]
53. Presence of benzo[a]pyrene diol epoxide adducts in target DNA leads to an increase in UV-induced DNA single strand breaks and supF gene mutations.
Routledge MN; McLuckie KI; Jones GD; Farmer PB; Martin EA
Carcinogenesis; 2001 Aug; 22(8):1231-8. PubMed ID: 11470754
[TBL] [Abstract][Full Text] [Related]
54. Cr(III)-mediated crosslinks of glutathione or amino acids to the DNA phosphate backbone are mutagenic in human cells.
Voitkun V; Zhitkovich A; Costa M
Nucleic Acids Res; 1998 Apr; 26(8):2024-30. PubMed ID: 9518499
[TBL] [Abstract][Full Text] [Related]
55. How are potent bulky carcinogens able to induce such a diverse array of mutations?
Loechler EL
Mol Carcinog; 1995 Aug; 13(4):213-9. PubMed ID: 7646760
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of the mutagenicity of benzo(a)pyrene diol epoxide by a nonmutagenic dose of ultraviolet A radiation.
Besaratinia A; Pfeifer GP
Cancer Res; 2003 Dec; 63(24):8708-16. PubMed ID: 14695185
[TBL] [Abstract][Full Text] [Related]
57. Mirror image stereoisomers of the major benzo[a]pyrene N2-dG adduct are bypassed by different lesion-bypass DNA polymerases in E. coli.
Seo KY; Nagalingam A; Miri S; Yin J; Chandani S; Kolbanovskiy A; Shastry A; Loechler EL
DNA Repair (Amst); 2006 Apr; 5(4):515-22. PubMed ID: 16483853
[TBL] [Abstract][Full Text] [Related]
58. Kinds of mutations formed when a shuttle vector containing adducts of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9, 10-tetrahydrobenzo[a]pyrene replicates in human cells.
Yang JL; Maher VM; McCormick JJ
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3787-91. PubMed ID: 3108878
[TBL] [Abstract][Full Text] [Related]
59. Structural characterization of a (+)-trans-anti-benzo[a]pyrene-DNA adduct using NMR, restrained energy minimization, and molecular dynamics.
Fountain MA; Krugh TR
Biochemistry; 1995 Mar; 34(10):3152-61. PubMed ID: 7880810
[TBL] [Abstract][Full Text] [Related]
60. Site-specific benzo[a]pyrene diol epoxide-DNA adducts inhibit transcription elongation by bacteriophage T7 RNA polymerase.
Choi DJ; Marino-Alessandri DJ; Geacintov NE; Scicchitano DA
Biochemistry; 1994 Jan; 33(3):780-7. PubMed ID: 8292606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
